Decreased PTEN levels triggered and increased secretion of CCL2 chemokine by metastatic tumor cells, resulting in recruitment of IBA1-expressing myeloid cells that enhanced proliferation and reduced apoptosis of metastatic tumor cells. This evidence concerns the gene AIF1 and neoplasm.